George A Calin

George A Calin is an active faculty member at The University of Texas MD Anderson Cancer Center, Houston, Texas. He serves as Ad Interim Chair of the Department of Cancer Biology within the Division of Discovery Science. He holds professorships in the Department of Translational Molecular Pathology and a joint appointment in the Department of Leukemia. Additionally, he is the Felix L. Haas Endowed Professor in Basic Science and Co-Director of the MD/PhD Program at the UT Graduate School of Biomedical Sciences. He also co-directs the RNA Interference and non-codingRNA Center at MD Anderson.

His research is centered on molecular oncology, with a strong emphasis on non-coding RNAs and their role in cancer development and progression. His work bridges basic science and clinical applications, particularly in leukemia and other hematologic malignancies. As a translational researcher, he integrates molecular pathology with functional genomics to identify novel biomarkers and therapeutic targets.

The publications listed (though not detailed in the provided text) would likely reflect a consistent focus on RNA biology, gene regulation in cancer, and discovery of non-coding RNA networks. These would span disciplines such as molecular biology, oncology, genetics, and biomedical informatics, with subfields including microRNA, long non-coding RNAs, tumor suppressors, oncogenes, gene expression profiling, and RNA therapeutics.

• Felix L. Haas Endowed Professor in Basic Science

Dr. Calin mentors through his role as Co-Director of the MD/PhD Program, guiding future physician-scientists. He leads research teams within the Department of Cancer Biology and the RNA Interference and non-codingRNA Center. While specific grants are not listed, his endowed professorship and leadership roles suggest substantial and sustained grant support. His collaborative structure includes dual and joint appointments across departments, reflecting an interdisciplinary approach to cancer research.

He leads and co-directs key research and academic units at MD Anderson, including the Department of Cancer Biology (as Ad Interim Chair) and the RNA Interference and non-codingRNA Center. These labs and teams are central to advancing discovery in non-coding RNA and its translational applications in oncology.